Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exagen (XGN) EPS (Weighted Average and Diluted) (2020 - 2025)

Exagen's EPS (Weighted Average and Diluted) history spans 6 years, with the latest figure at -$0.2 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) changed 0.0% year-over-year to -$0.2; the TTM value through Dec 2025 reached -$0.92, down 10.84%, while the annual FY2025 figure was -$0.93, 12.05% down from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.2 in Q4 2025 per XGN's latest filing, up from -$0.31 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.16 in Q2 2024 to a low of -$0.86 in Q2 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.38, with a median of -$0.31 recorded in 2023.
  • Peak YoY movement for EPS (Weighted Average and Diluted): plummeted 126.32% in 2022, then skyrocketed 67.44% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.41 in 2021, then plummeted by 102.44% to -$0.83 in 2022, then surged by 62.65% to -$0.31 in 2023, then soared by 35.48% to -$0.2 in 2024, then dropped by 0.0% to -$0.2 in 2025.
  • Per Business Quant, the three most recent readings for XGN's EPS (Weighted Average and Diluted) are -$0.2 (Q4 2025), -$0.31 (Q3 2025), and -$0.21 (Q2 2025).